These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 18557522)

  • 1. [Study of the virulence of Actinobacillus pleuropneumoniae in finishing pigs as a basis for vaccination development].
    Hennig-Pauka I; Baltes N; Jacobsen I; Stratmann-Selke J; Gerlach GF; Selbitz HJ; Waldmann KH
    Berl Munch Tierarztl Wochenschr; 2008; 121(5-6):189-97. PubMed ID: 18557522
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of immunogenicity and protective efficacy of Actinobacillus pleuropneumoniae HB04C(-) mutant lacking a drug resistance marker in the pigs.
    Bei W; He Q; Zhou R; Yan L; Huang H; Chen H
    Vet Microbiol; 2007 Nov; 125(1-2):120-7. PubMed ID: 17580102
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of a DIVA subunit vaccine against Actinobacillus pleuropneumoniae infection.
    Maas A; Meens J; Baltes N; Hennig-Pauka I; Gerlach GF
    Vaccine; 2006 Nov; 24(49-50):7226-37. PubMed ID: 17027123
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Construction and immunogenicity of an attenuated mutant of Actinobacillus pleuropneumoniae by insertional inactivation of apxIC].
    Xu FZ; Shi AH; Chen XL; Yang B; Wang JL
    Wei Sheng Wu Xue Bao; 2007 Oct; 47(5):923-7. PubMed ID: 18062275
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Positive role for rApxIVN in the immune protection of pigs against infection by Actinobacillus pleuropneumoniae.
    Wang C; Wang Y; Shao M; Si W; Liu H; Chang Y; Peng W; Kong X; Liu S
    Vaccine; 2009 Sep; 27(42):5816-21. PubMed ID: 19654060
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization and immunogenicity of an apxIA mutant of Actinobacillus pleuropneumoniae.
    Xu F; Chen X; Shi A; Yang B; Wang J; Li Y; Guo X; Blackall PJ; Yang H
    Vet Microbiol; 2006 Dec; 118(3-4):230-9. PubMed ID: 16930871
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of protective immune responses against challenge of Actinobacillus pleuropneumoniae by oral administration with Saccharomyces cerevisiae expressing Apx toxins in pigs.
    Shin MK; Kang ML; Jung MH; Cha SB; Lee WJ; Kim JM; Kim DH; Yoo HS
    Vet Immunol Immunopathol; 2013 Jan; 151(1-2):132-9. PubMed ID: 23206402
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of different doses of antigen for intradermal administration in pigs: the Actinobacillus pleuropneumoniae model.
    Bernardy J; Nechvatalova K; Krejci J; Kudlacková H; Brazdova I; Kucerova Z; Faldyna M
    Vaccine; 2008 Nov; 26(50):6368-72. PubMed ID: 18824203
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Actinobacillus pleuropneumoniae vaccines: from bacterins to new insights into vaccination strategies.
    Ramjeet M; Deslandes V; Gouré J; Jacques M
    Anim Health Res Rev; 2008 Jun; 9(1):25-45. PubMed ID: 18346296
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Attenuated Actinobacillus pleuropneumoniae double-deletion mutant S-8∆clpP/apxIIC confers protection against homologous or heterologous strain challenge.
    Xie F; Li G; Zhou L; Zhang Y; Cui N; Liu S; Wang C
    BMC Vet Res; 2017 Jan; 13(1):14. PubMed ID: 28061786
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of endobronchial challenge with Actinobacillus pleuropneumoniae serotype 9 of pigs vaccinated with inactivated vaccines containing the Apx toxins.
    Chiers K; van Overbeke I; De Laender P; Ducatelle R; Carel S; Haesebrouck F
    Vet Q; 1998 Apr; 20(2):65-9. PubMed ID: 9563163
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protection of mice and swine against infection with Actinobacillus pleuropneumoniae by vaccination.
    Beaudet R; McSween G; Boulay G; Rousseau P; Bisaillon JG; Descoteaux JP; Ruppanner R
    Vet Microbiol; 1994 Mar; 39(1-2):71-81. PubMed ID: 8203129
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Experimental infection of SPF pigs with Actinobacillus pleuropneumoniae serotype 9 alone or in association with Mycoplasma hyopneumoniae.
    Marois C; Gottschalk M; Morvan H; Fablet C; Madec F; Kobisch M
    Vet Microbiol; 2009 Mar; 135(3-4):283-91. PubMed ID: 18977616
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Construction and characterization of Actinobacillus pleuropneumoniae serovar 7 live attenuated vaccine strain co-expressing ApxIA].
    Liu J; Chen Y; Hu L; Bei W; Chen H
    Sheng Wu Gong Cheng Xue Bao; 2010 Mar; 26(3):305-10. PubMed ID: 20518341
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of subclinical infection with Actinobacillus pleuropneumoniae in commingled feeder swine.
    Rohrbach BW; Hall RF; Hitchcock JP
    J Am Vet Med Assoc; 1993 Apr; 202(7):1095-8. PubMed ID: 8473222
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The induction of specific protection against Actinobacillus pleuropneumoniae infection by specific DLE.
    Snirc J; Mikula I; Pistl J
    Acta Microbiol Hung; 1993; 40(4):325-33. PubMed ID: 7976208
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk assessment of transmission of capsule-deficient, recombinant Actinobacillus pleuropneumoniae.
    Inzana TJ; Glindemann G; Fenwick B; Longstreth J; Ward D
    Vet Microbiol; 2004 Nov; 104(1-2):63-71. PubMed ID: 15530740
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of endobronchial challenge with Actinobacillus pleuropneumoniae serotype 9 of pigs vaccinated with a vaccine containing Apx toxins and transferrin-binding proteins.
    Van Overbeke I; Chiers K; Ducatelle R; Haesebrouck F
    J Vet Med B Infect Dis Vet Public Health; 2001 Feb; 48(1):15-20. PubMed ID: 11254095
    [TBL] [Abstract][Full Text] [Related]  

  • 19. AasP autotransporter protein of Actinobacillus pleuropneumoniae does not protect pigs against homologous challenge.
    Oldfield NJ; Worrall KE; Rycroft AN; Ali T; Wooldridge KG; Ala'Aldeen DA
    Vaccine; 2009 Aug; 27(38):5278-83. PubMed ID: 19563888
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deletion of the znuA virulence factor attenuates Actinobacillus pleuropneumoniae and confers protection against homologous or heterologous strain challenge.
    Yuan F; Liao Y; You W; Liu Z; Tan Y; Zheng C; BinWang ; Zhou D; Tian Y; Bei W
    Vet Microbiol; 2014 Dec; 174(3-4):531-539. PubMed ID: 25465668
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.